Virtus ETF Advisers LLC Design Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$2.05 - $8.14 $3,739 - $14,847	-1,824 Reduced 9.06%	18,313 $43,000
Q2 2023 Aug 14, 2023	BUY	$4.99 - $7.64 $43,617 - $66,781	8,741 Added 76.7%	20,137 $126,000
Q1 2023 May 15, 2023	SELL	$5.5 - $9.77 $24,079 - $42,773	-4,378 Reduced 27.75%	11,396 $65,000
Q4 2022 Feb 14, 2023	BUY	$7.86 - $17.2 $62,872 - $137,582	7,999 Added 102.88%	15,774 $161,000
Q3 2022 Nov 14, 2022	BUY	$14.09 - $25.57 $831 - $1,508	59 Added 0.76%	7,775 $130,000
Q2 2022 Aug 12, 2022	BUY	$9.91 - $17.33 $76,465 - $133,718	7,716 New	7,716 $108,000

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $314M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.